Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-035752

OCULAR THERAPEUTIX, INC · OCUL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amarpreet Sawhney
Officer — President and CEO · Director · 10% Owner
Period of report
Dec 15, 2016
Accepted (ET)
Dec 16, 2016 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 15, 2016P45,300$7.85A677,390D
Common StockF2holding———846,377ISee Footnote
Common StockF3holding———471,784ISee Footnote
Common StockF4holding———379,419ISee Footnote
Common StockF5holding———71,969ISee Footnote
Common StockF6holding———189,393ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses